Skip to main content
Molecules logoLink to Molecules
. 2020 Jun 5;25(11):2635. doi: 10.3390/molecules25112635

Characteristics of Panax ginseng Cultivars in Korea and China

Hao Zhang 1,2, Suleman Abid 3, Jong Chan Ahn 3, Ramya Mathiyalagan 3, Yu-Jin Kim 3, Deok-Chun Yang 3,*, Yingping Wang 1,*
Editor: Ik-Hyun Cho
PMCID: PMC7321059  PMID: 32517049

Abstract

Ginseng (Panax ginseng Meyer) is one of the most important medicinal herbs in Asia. Its pharmacological activity comes from ginsenosides, and its roots are produced commercially for traditional and Oriental medicine. Though 17 Panax species are available around the world, there was a need to develop cultivars adapted to different climatic conditions and resistant to various diseases while still producing high-quality, high-yield roots. Thus, 12 and 9 commercial P. ginseng cultivars have been registered in South Korea and China, respectively. Those varieties show superiority to local landraces. For example, Chunpoong is more highly resistant to rusty rot disease than the local Jakyungjong landrace and has a good root shape; it is highly cultivated to produce red ginseng. The Chinese cultivar Jilin Huangguo Renshen has higher ginsenoside content than its local landraces. This review provides information about P. ginseng cultivars and offers directions for future research, such as intra- and interspecific hybridization.

Keywords: Panax ginseng, ginseng species, Panax ginseng cultivars, Chunpoong, Jilin Huangguo Renshen

1. Introduction

Ginseng, which belongs to the genus Panax and family Araliaceae, is widely used in East Asia as an herbal medicinal plant, as it has excellent medicinal properties [1]. Particularly in Korea, China, and Japan, ginseng is considered to be the most important of all medicinal herbs. For the past 2000 years, people from those places have used ginseng root and its extract as a stimulant to relieve stress and fatigue, strengthen the body and mind, prevent aging, and increase vigor [2,3]. The Panax genus consists of 17 species, but P. ginseng (Asian or Korean ginseng), P. quinquefolius (American ginseng), and P. notoginseng (Chinese ginseng) are the species most commonly used as a functional food and medicine [4]. The genus Panax, first used by the Russian botanist, Carl A Meyer [5], is derived from the Greek pan, meaning “all”, and axos, meaning “medicine”, indicating that ginseng is a cure for all diseases [6]. Due to the resemblance between the ginseng root and the human shape, the English name “ginseng” was introduced from the Chinese word “renshen” [7].

According to the archaeological evidence, pharmaceutical use of ginseng originated in the Paleolithic period more than 60,000 years ago. The world’s oldest pharmacopeia of medicinal herbs and plants, Shennong’s Herbal Classic [8], organizes herbs into three classes by their degree of toxicity. Ginseng was deemed to be a nontoxic medicinal plant and recommended for regular use to increase energy [9]. For a long time, human beings have been using medicinal plants as beverages, nutrients, dyes, cosmetics, and medicines to improve their quality of life and maintain good health [8].

Around the world, especially in Asia, many people still depend on herbal medicines to treat and prevent different health conditions. The World Health Organization reported that 80% of the worldwide population depends on herbal medicines as supplemental or alternative medicines [10]. According to the yin and yang theory, ginseng, “the king of all herbs” plays a vital role in the pharmacopeia and is valued for its significant therapeutic properties [11], many of which have been validated, including its anti-inflammatory [12], antioxidative [13], anti-obesity [14], anti-allergic [15], antihypertensive [16], memory improvement [17], sexual potentiation [18,19], anti-diabetic [20], and antitumor [21] properties. Ginseng also modulates metabolism, immune functions, and blood pressure [22]. The mechanism of ginseng’s action remained unidentified until secondary metabolites such as ginsenosides were isolated in 1963. Since then, much effort has been focused on evaluating the mechanism and function of each ginsenoside because different species of ginseng vary in ginsenoside content. Furthermore, a single species cultivated in different locations can have pharmacological differences. Ginseng has many ginsenosides, each of which can have many pharmacological effects. Furthermore, non-ginsenoside bioactive components in ginseng also have pharmacological properties. Therefore, it is not astonishing that the whole activity of the herb is complex and still needs more exploration [22]. Nonetheless, most Panax species are morphologically similar, though their origin is not completely understood. Cytogenetic data have been used to explore their origin distribution, but still more research is needed to fully understand the phylogenetic relationships among Panax species [23]. Also, plant secondary metabolites are often used for medicinal purposes, and ginseng has different kinds of secondary metabolites (Table 1).

Table 1.

Secondary metabolites produced by ginseng.

No Compounds Medicinal Properties References
1. Ginsenoside Anti-cancer, Anti-diabetes, Anti-inflammation, Hepatoprotection, Anti-aging, Anti-oxidative [30,31,32,33,34]
2. Phytosterol (Stigmasterol and β-sterol) Lower the cholesterol level [35,36]
3. Sesquiterpenes (β-elemene and β-selinene) - [35,37,38]
4. Flavonoids (Kaempferol) Anti-oxidant, Hepatoprotective, Anti-cancer, Anti-inflammatory, Anti-viral [35,39]
5. Polyacetylenes (Panaxynol, Ginsenoyne A) Possess Anti-tumor properties [35,40]
6. Alkaloids (Fumarine, Girinimbin) - [35,41]
7. Phenolic Compounds (Elemicin, Dauricine, Maltol) Anti-tumor, Anti-oxidant, Anti-inflammatory [3,35,42,43]

Customers need to understand ginseng species and cultivars so they can make correct choices for medicine. P. ginseng (Asian or Korean ginseng) is used as a restorative medicine [24]. P. quinquefolius (American ginseng) is also used to treat thirst, fatigue, dryness of the mouth, the respiratory tract, and irritability [25]. Asian ginseng and American ginseng have different types of ginsenosides, including Rf and F11, respectively, that are missing from pseudo-ginseng. Other ginseng species are P. notoginseng (Sanchi ginseng) [26], P. japonicus (Japanese ginseng) [27], P. vietnamensis (Vietnam ginseng) [28], P. pseudoginseng, P. assamicus, P. shangianus, P. variabilis, P. major Ting, P. omeiensis, P. sinensis, P. stipuleanatus, P. trifolius, P. wangianus, and P. zingiberensis [29] (Table 2). Generally, people only use good brands or famous species for pharmaceutical purposes.

Table 2.

The list of seventeen Panax species in the world.

No. Ginseng Species Common Names References
1 P. ginseng Korean ginseng [23,24,44,45,46,47,48] https://www.biodiversitylibrary.org/
2 P. quinquefolius American ginseng [45,49,50], https://www.biodiversitylibrary.org/, http://powo.science.kew.org/
3 P. notoginseng Chinese ginseng [45,47], http://powo.science.kew.org/, https://www.gbif.org/
4 P. japonicas Japanese ginseng [45,51,52], http://powo.science.kew.org/
5 P. omeiensis Omei ginseng [43,53]
6 P. pseudoginseng Himalayan ginseng [45,54,55] http://powo.science.kew.org/
7 P. assamicus N/A [45,56] http://powo.science.kew.org/
8 P. shangianus N/A [57,58]
9 P. sinensis N/A [43,57]
10 P. stipuleanatus Pingpien ginseng [43,56], https://www.gbif.org/, http://powo.science.kew.org/, https://www.ipni.org/
11 P. trifolius Dwarf ginseng [45,59], https://www.biodiversitylibrary.org/
12 P. variabilis N/A [56,57]
13 P. vietnamensis Vietnamese ginseng [57,58], https://www.gbif.org/, http://powo.science.kew.org/, https://www.ipni.org/
14 P. wangianus Narrow-leaved pseudoginseng [43,57], http://powo.science.kew.org/, https://www.gbif.org/, https://www.ipni.org/
15 P. bipinnatifidus Feather-leaf bamboo ginseng [45,60], http://powo.science.kew.org/
16 P. sokpayensis N/A [60], http://powo.science.kew.org/
17 P. zingiberensis Ginger ginseng [43,56,57,58], http://powo.science.kew.org/, https://www.ipni.org/

2. Phytochemistry of Panax ginseng

Ginseng produces various kinds of secondary metabolites that have important biological purposes. The ability to perform in vivo combinative chemistry by evolving the genes needed for different secondary metabolite biosynthetic pathways is likely to have been difficult in the diversification of different plants. Terpenes are secondary metabolites found in various kinds of plant-based products [61]. Numerous secondary metabolites, including saponins, polysaccharides, flavonoids, and amino acids have been found in Panax plants. Saponins, also known as ginsenosides, are the main bioactive constituents of the pharmacological efficacy in natural medicines derived from Panax species. The well-known ginsenosides have different chemical structures [62], with different medicinal properties as shown in Table 3. In ginseng, the most unique compounds are the ginsenosides (panaxosides), which are present in the form of saponins, including the triterpene saponins [63]. Ginsenosides are divided into two groups (Figure 1): dammarane and oleanane, which have four- and five-ring carbon skeletons, respectively [64]. Ginsenosides are generally represented as “Rx”, where the “R” stands for the root and the “x” defines the chromatographic polarity [5]. Dammarane groups are further divided into protopanaxadiol (PPD) groups Rb1, Rb2, Rc, and Rd, and protopanaxatriol (PPT) groups Re, Rf, Rg1, and Rg2 (Figure 1) with different sugar moieties that are attached to the C-3 and C-20 positions or C-6 and C-20 positions, respectively. At least 289 ginseng saponins were reported from eleven Panax species at the end of the year 2012 [62]. The presence of these compounds increases the value of ginseng in the medicinal field worldwide. Furthermore, ginsenosides yields vary in ginseng species due to the different cultivation methods and different chemical structures [2,65,66].

Table 3.

Some of the ginsenoside structures and its medicinal properties..

No. Species Chemical Structure Medicinal Properties References
1. Pg, Pq, Pn, Pj graphic file with name molecules-25-02635-i001.jpg Anti-arthritic, Central inhibition and mental stability, Promoting protein synthesis, Cold tolerance [2,67,68,69,70]
graphic file with name molecules-25-02635-i002.jpg Anti-nociception, Immune modulating, Wound healing, Inhibits angiogenesis [2,3,71]
graphic file with name molecules-25-02635-i003.jpg Anti-inflammatory, Anti-arthritic, Anti-gastritis [2,72,73]
graphic file with name molecules-25-02635-i004.jpg Anti-hypertension, Anti-oxidant, Free radical scavenger, Immunological adjuvant activity [2,74,75]
graphic file with name molecules-25-02635-i005.jpg Non-genomic effects in endothelial cells, Enhance Angiogenic, Anti-diabetes [2,76,77]
graphic file with name molecules-25-02635-i006.jpg Anti-nociception, Pain inhibition, Inhibition of lipid peroxidation, Physiological saline control [2,78,79]
graphic file with name molecules-25-02635-i007.jpg Anti-coagulation, Anti-platelet aggregation, Prolonged clotting time, Anti-diabetes [2,77,80]
graphic file with name molecules-25-02635-i008.jpg Anti-apoptosis, Anti-oxidation, Neuroprotective, Treatment for Alzheimer’s disease [2,81]
2. Pg, Pq, Pj graphic file with name molecules-25-02635-i009.jpg Inhibit the replication of HIV-1, Reduced ischemic brain injury [2,82,83]
3. Pq, Pn graphic file with name molecules-25-02635-i010.jpg Assists memory improvement neuroprotective [2,29]

Note: Panax ginseng (Pg), Panax quinquefolius (Pq), Panax notoginseng (Pn), Panax japonicus (Pj).

Figure 1.

Figure 1

Classification of ginsenosides by chemical structure.

3. Breeding Method for the Development of Ginseng Cultivars

Ginseng (P. ginseng) is a perennial and self-fertilized plant. Ginseng breeding is difficult because it takes four years of growth for seed production, and even after four years, ginseng produces very few seeds [84]. Different cultivars have been developed from P. ginseng species through pedigree breeding programs to select good characteristics from local landrace populations such as Hwangsook, Chungkyung, and Jakyung. Initially, local landraces were differentiated and selected by morphological characteristics, including stem and berry colors. Cultivars with good characteristics were chosen by judging the characteristics of individual plants in a farmer’s field, and then inbreeding was done by pedigree in Korea [85]. In the pedigree method, good individual plants are segregated for generations, and their progeny are checked in succeeding generations. Later, the pure line selection method was used to develop ginseng cultivars from P. ginseng. Pure line selection can use two different methods, line separation and propagation on the one hand, and hybridization (crossbreeding, reciprocal crosses, and mutant breeding) on the other. The line separation and propagation method uses three steps. In the line fixing step, we check the plants’ resistance to disease, salt, light, and temperature. The second step is the product performance test, and the final step tests regional adaptability in field trials. This process requires 5–6 generations and 20–24 years to develop a new cultivar. For the hybridization method, good individual plants are selected for breeding; this method also requires 5–6 generations and 20–24 years to develop a new cultivar [86,87].

4. Panax ginseng Cultivars in Korea

4.1. Chunpoong

Chunpoong is a P. ginseng cultivar developed by Woo-Saeng Kwon. To develop this new cultivar, many different individual ginseng plants were screened for high yield and good quality in a farmer’s fields in 1972. Many lines were selected, and a favorable one, 7259-3-1, was produced at the Korea Ginseng & Tobacco Research Institute by comparative cultivation using the pure line separation method. After it passed yield and adaptation trials, it was commercialized as Chunpoong [84]. Chunpoong has a high yield, good quality, and high resistance to ginseng rust rot disease. It has a green stem with light violet and orange-yellow flowers and fruits 37 days later than the local landrace, Jakyungjong. Chunpoong has an average stem length, stem diameter, leaflet length, leaflet width, palmate cleaves, and number of leaflets of 38.5 cm, 7.4 mm, 15.9 cm, 6.3 cm, 5.6, and 22.7, respectively. The below-ground sections of a four-year-old plant have an average main root length, diameter, and root weight of 8.3 cm, 27.0 mm, and 61.0 g, respectively. The taproot (main root) of Chunpoong is longer than that of the local landrace, and the root yield of Chunpoong is 9% greater than that of Jakyungjong. In red ginseng quality, the rates of Chun-Jeesam (“Chun” and “Jee” stand for first- and second-grade root ginseng, respectively) were 22.3% and 9.4% for Chunpoong and Jakyungjong, respectively. Due to its good root shape, it is widely used to produce red ginseng. Chunpoong has high market demand at the commercial level and is the most-grown cultivar of P. ginseng in South Korea (Figure 2) [88].

Figure 2.

Figure 2

P. ginseng cultivars in Korea. All cultivars have superiority over the parents produced by pure-line selection breeding methods.

4.2. Yunpoong

Yunpoong was designated as KG-102 during its development, and then it was registered as the new cultivar Yunpoong by the Korea Ginseng & Tobacco Research Institute. It was developed using comparative cultivation of several lines selected with pure line separation from local landraces. In its mature stage, we can easily differentiate the Yunpoong cultivar. The flowering date of Yunpoong is earlier than that of other P. ginseng cultivars, and it forms more double ovary–type flowers. It has variant features and high yield, is widely cultivated, and has good root weight and a very thick root, which is helpful to the mass production of ginseng. The ratio of taproot length to the diameter of the taproot length is less in Yunpoong than in Jakyungjong, but the four-year-old root yield of Yunpoong is 27.3% more than that of Jakyungjong. This cultivar is widely used for mass production (Figure 2) [89].

4.3. Gopoong

Gopoong is also a P. ginseng cultivar introduced by Woo-Saeng Kwon using the same procedures just described for Chunpoong and Yunpoong. A promising line, 680-83-4, was named KG-103 and then registered with the Korea Seed & Variety Service (http://www.seed.go.kr) as the new cultivar Gopoong at the commercial level. It has a unique phenotype: a reddish or dark violet stem, dark red fruit, high saponin content, good looking root shape, and an inverted triangle shape of berries clusters, unlike other cultivars of P. ginseng. Gopoong shows a purple color around the stems and along the length of the petiole and peduncle. The four-year-old taproot of Gopoong is long, and the root yield is 4.5% higher than that of Jakyungjong. It also has red ginseng quality, with excellent grades of Chun-Jeesam. The ratio of red ginseng quality is 16.6% in Gopoong and 9.4% in Jakyungjong. As shown by this ratio, Gopoong is a superior P. ginseng cultivar with good quality for the production of red ginseng products (Figure 2) [90,91].

4.4. Sunpoong

P. ginseng cultivars have been developed to improve the root quality and yield. The characteristics of the Chunpoong cultivar are better than those of the local landraces. For example, its production of heaven- and earth-grade ginseng is 613% higher than that of the local variants, but its average root weight is less. Thus, the average grade of raw Chunpoong ginseng is lower than that of the local variants. Therefore, it was essential to breed a variant with a high rate of heaven and earth grades and heavy root weight. A superior line, 7224-1-1, was selected for testing and breeding due to the long length of its peduncle, and it was then registered as KG104 by the Korean Ginseng Corporation. After checking its productivity in adaptation experiments from 1981 to 1984, its three-year-old ginseng root weight was 15.4% higher than that of Chunpoong, and the new cultivar was approved as Sunpoong. Sunpoong has an early germination time. It has purple stems, a round and simple kind of inflorescence and berries, and stolon roots. Its berries and autumn leaves are red, its roots have a creamy color, and its leaflets are wide and elliptical. Sunpoong is a high yielding cultivar in terms of its average root weight. Its 1st- and 2nd-grade ginseng root percentages are higher than those of Yunpoong, 20.9% and 9.4%, respectively (Figure 2) [91,92].

4.5. Gumpoong

Gumpoong is also an excellent cultivar of P. ginseng, with good root shape and high yield that make it suitable for the production of red ginseng. It originated from the landrace Hwangsook [93]. Gumpoong was discovered in Gaepung-gun, Gyeonggi-do, in 1926 and in Jangdan-gun, Gyeonggi-do, in 1928. It has green stems, and its mature fruits are yellow, so it is also called the yellow berry cultivar. Studies have been conducted on the aerial part during flowering to characterize Gumpoong in terms of its relative elongation, saponin content, chlorophyll content, mineral content, and the photosynthetic content of its leaves and roots. Gumpoong was selected for its high resistance to rust roots in the Punggi area in 1979. Its characteristics were examined from 1979 to 1992, and then it was registered as the approved cultivar Gumpoong in 1996. Regarding its qualitative characteristics, Gumpoong does not have purple (or anthocyanin) in the stems, and its berries and inflorescence are simple and round. Its stem color is green, with yellow berries, yellow autumn leaves, a creamy root color, and broad elliptical leaflets. Its average stem length, stem diameter, leaflet length, leaflet width, palmate cleaves, and number of leaflets are 35.5 cm, 7.6 mm, 16.3 cm, 7.1 cm, 5.5, and 23.6, respectively, and its three-year-old main root average length, diameter, and root weight are 7.6 cm, 26.8 mm, and 70.2 g, respectively. Its average rates of heaven- and earth-grade ginseng are 21.2% and 12.8%, respectively (Figure 2) [85,91].

4.6. Cheongsun

Cheongsun was first introduced in Jangdan-gun, Gyeonggi-do, in 1927 as a green-stem variant with red berries. The same variant was produced at the Ginseng and Tobacco Research Institute, Jeungpyeong in Chungcheongbuk-do, South Korea in 1978. Studies with different entities were conducted for stem color distribution in 1988. Most entities showed green stems and red berries, but some showed green and purple stems in a 3:1 ratio. No significant differences were found in respiration or photosynthesis between the green-stem variant, the violet-stem variant, and the yellow berry variant. The susceptibility to root rot, cracking, and rusty roots were studied, and the yellow-berry variant and violet-stem variant did not differ significantly. In 1978, the green-stem variant, with green stems, peduncle, and petiole and red berries, was selected at the Ginseng & Tobacco Research Institute, Jeungpyeong. After breeding trials, the green-stem variant was registered as a new variety, Cheongsun, in 1991, and adaptation trials were completed in 1999. The qualitative features of Cheongsun are no purple in the stems, round and simple berries and inflorescence, and stolon roots. Cheongsun has red autumn leaves, broad elliptical leaflets, and a creamy root color. The average stem length, stem diameter, leaf length, leaf width, palmate cleaves, and number of leaflets of Cheongsun are 32.2 cm, 7.0 mm, 14.7 cm, 6.7 cm, 4.8, and 23.8, respectively. The three-year-old main root average length, diameter, and root weight are 8.6 cm, 25.4 mm, and 73.7 g, respectively. For the quality of red ginseng, the average rates of heaven- and earth-grade ginseng are 14.6% and 7.2%, respectively (Figure 2) [91,93,94].

4.7. Sunhyang

The Sunhyang P. ginseng cultivar was bred from Chunpoong (for its good morphological characteristics), Yunpoong (for its excellent yield), and Gopoong (for its high saponin content). Over time, more ginseng cultivars are being introduced because people are interested in using ginseng variants to promote a healthy lifestyle. Studies have been done for red ginseng taste, aromatic ingredients, and the identification of ginseng volatile compounds by gas chromatography and mass spectrometry. Entity 78093 was used for breeding from 1979 to 1981 and then named KG110. During those studies, it was realized that this variant had a high content of Aroma-1, which led to its approval as a new cultivar, Sunhyang. The aerial sections of Sunhyang are characterized by purple stems rich in anthocyanin, inflorescence, and simple, round berries. Sunhyang has stolon roots, red berries, red autumn leaves, broad elliptical leaflets, and cream-colored roots. The average stem length, stem diameter, leaf length, leaf width, palmate cleaves, and number of leaflets are 39.6 cm, 6.6 mm, 14.9 cm, 6.5 cm, 4.8, and 23.8, respectively. The main root average length is 7.4 cm, the average diameter of the main root is 29.0 mm, and the average root weight is 78.8 g. For the quality of red ginseng, the average rates of heaven- and earth-grade ginseng are 13.3% and 14.1%, respectively (Figure 2) [91,94,95].

4.8. Sunun

Self-fertilization occurs in ginseng, and breeding procedures mostly depend on the morphological characteristics of the aerial and below-ground sections, due to its limited genetic resources. Thus, different cultivars have been developed by selecting for good morphological appearance. A variant was selected with strong blistering on the leaflet surface in 1985, and then in 1989, a purple-stem population of that variant was approved as the Sunun cultivar. The aerial part of Sunun has purple stems, inflorescence, round and simple berries, and stolon roots. The berries and autumn leaves are red. The leaflets are broad and elliptical, and the root color is cream. The average stem length, stem diameter, leaf length, leaf width, palmate cleaves, and number of leaflets are 29.0 cm, 6.9 mm, 16.2 cm, 7.0 cm, 4.5, and 24.3 respectively. The three-year-old main root average length, diameter, and root weight are 8.2 cm, 26.5 mm, and 67.8 g, respectively. For the quality of red ginseng, the average rates of heaven- and earth-grade ginseng are 16.4% and 18.0%, respectively (Figure 2) [91].

4.9. Sunone

Root rot is one of the major diseases in ginseng and causes yield reduction in ginseng cultivation. Root rot disease also disturbs the continuous cropping of ginseng. To produce a rot-resistant root ginseng cultivar, several resistant variants were selected in 1982, including 680-29-1. Sunone cultivation began with a purple-stem landrace, and one entity with a purple stem, broad leaves, and six round, palmately compound leaves chosen at the production site. It was labeled 78135 and selected as the first rot-resistant root variant in 1996. In 2000, after adaptation testing, it was registered as the new variety, Sunone. The aerial part of Sunone has anthocyanin-rich purple stems, inflorescence, round and simple berries, and stolon roots. The berries and autumn leaves of Sunone are red. The leaflets are broad and elliptical, and the root color is cream. The average stem length, stem diameter, leaf length, leaf width, palmate cleaves, and number of leaflets are 35.4 cm, 7.5 mm, 15.7 cm, 6.8 cm, 4.5, and 24.4, respectively. The three-year-old main root average length, diameter, and root weight are 8.5 cm, 25.3 mm, and 84.1 g, respectively. For the quality of red ginseng, the average rates of heaven- and earth-grade ginseng are 1.9% and 6.8%, respectively. It has 61.1% resistance against root rot, but that depends on its age (Figure 2) [91].

4.10. K-1

The cultivation of K-1, one of the superior cultivars of P. ginseng, began in 1984. It is perfect for making red ginseng due to its good root shape, and it also has productive lateral roots and high disease resistance. K-1 is widely cultivated in many ginseng planting areas, including Chuncheon, Buyeo, and Gochang [1]. The growth characteristics of the roots in five-year-old K-1 plants begun by direct seeding are the main root length, diameter, and root weight of 10.6 cm, 20.0 mm, and 37.1 g, respectively (Figure 2) [1,96].

4.11. G-1

A new cultivar of P. ginseng, G-1, with different yield and ginsenoside content was developed in 2012. The morphological features of G-1 are violet stems that are stronger than Chunpoong, short flower stalks, budding later than Sunpoong, and red berries. The G-1 root appearance, disease resistance, and ginsenoside content were also analyzed (Figure 2) [97].

4.12. Kowon

In recent times, plant breeders have focused on developing new ginseng cultivars with higher resistance to biotic and abiotic stress. In 1999, seeds were collected from a farm in Suwon, Korea. After four years, good samples were screened for further evaluation, and from 2003 to 2007 cultivation and propagation characteristics were checked. In the elite line G03136-3, different yield trials were done from 2008 to 2010, and then the line was assigned the name Korea No. 1. After local adaptability tests from 2011 to 2013, Korea No. 1 was much-admired for its resistance to Alternaria blight and high yield. In November 2013, it was registered as a new cultivar named Kowon. The Kowon cultivar has broad green elliptical leaves with plain leaflets, yellowish-green stems, red fruits, and cream-colored roots. The main roots are cylindrical and intermediate in size compared with Yunpoong and Chunpoong. The growth characteristics of four-year-old Kowon ginseng are reflected by stem length, number of stems per plant, leaf length, leaf width, and number of leaves of 31.3 cm, 1.1, 17.5 cm, 7.3 cm, and 25, respectively. The root length, fresh weight, and diameter are 27.7 cm, 46.8 g, and 4.6 cm, respectively (Figure 2) [98].

4.13. Summary of Panax ginseng Cultivars in Korea

The preceding P. ginseng cultivars are well-developed cultivars from local landraces. The main purposes for breeding the different cultivars from 1970 to the late 1990s were high yield, quality of red ginseng, physical properties, high ginsenoside content, and disease resistance. However, due to increasing interest in red ginseng (for its pharmacological properties), attention has moved to develop cultivars resistant to high temperatures and with a high content of non-saponin bioactive components. Ginseng is a half-shade medicinal plant, and its growth can be reduced by intense light and high temperature [97,98,99]. To overcome these environmental problems and improve various characteristics related to ginsenoside production, several cultivars have been produced. Most of those cultivars were produced from Chunpoong and Yunpoong, which already have good morphology and high yield. Cultivars such as Chunpoong and Gumpoong are highly resistant to rust rot disease, Sunone is highly resistant to root rot disease, and Kowon is resistant to the Alternaria blight. The Sunun cultivar was the first to develop strong blistering on the surface of its leaflets. A high content of Aroma 1 is produced by the Sunhyang cultivar. Gopoong is mostly used for red ginseng products, and Yunpoong produces high root yields. Chunpoong, Yunpoong, Sunpoong, and Gumpoong are all good, reliable cultivars for red ginseng quality.

5. Panax ginseng Cultivars in China

5.1. Jilin Huangguo Renshen

A mutant ginseng plant with yellow mature fruit and green stems was discovered in Fusong County, Jilin province, in 1959. Subsequently, this plant was self-fertilized and propagated for several generations. The offspring showed stable heritability of yellow berries and green stems. Yellow-berry ginseng is a homozygous recessive mutant of red-berry ginseng. Comparisons between yellow- and red-berry ginseng have been conducted on agronomic traits, production, photosynthetic rate, and chemical constituents, including saponin. Very few differences are observed between them, but yellow-berry ginseng has significantly higher ginsenoside content and photosynthetic rate than red-berry ginseng (Figure 3) [100]. Based on its high ginsenoside content and yellow fruit, this population was kept continuously for self-fertilization for three generations. The selected group showed strong genetic stability in fruit color and ginsenoside content. Regional and production experiments were performed from 1981 to 1996, and it was finally registered as Jilin Huangguo Renshen in 1998.

Figure 3.

Figure 3

P. ginseng cultivars in China. Highly improved cultivars from elite lines having various characters regarding medicinal purposes.

5.2. Jishen 01

To meet the requirements of ginseng growers in the eighteenth century, Jishen 01 was bred for its high production and good root shape. Originally, four inbred lines from the Ji’an region were selected to test eleven traits (yield, root weight, seedling survival, root length, main root length, root diameter, rhizome length, stem height, stem diameter, leaf length, and leaf width) (Figure 3). The inbred line G2, which showed the highest yield and excellent commodity characteristics, acquired the highest score in a comprehensive evaluation. In regional and production experiments, the yield of G2 was 15% higher, on average, than the local control population [101,102]. Jishen 01, which grows well in the Jilin, Liaoning, and Heilongjiang provinces, has heavy root weight, a long main root, good root shape, and a broad adaptation area.

5.3. Fuxing 01

Fuxing 01 offers high yield, strong comprehensive resistance, short main root length, high root diameter, short rhizome length, large stem scar, and many fibrous roots and was registered in 2009. Fuxing 01 is suitable for growing in regions with an altitude lower than 1000 meters and 90–130 frost-free days. This cultivar was selected from the landrace Damaya, which formed in the specific geographical environment and climatic conditions of the Fusong region. A Damaya population was purified at Fusong State Ginseng Farm from 1989 to 2002 and named FX01. Then, regional and production experiments were performed in Changbai, Fusong, and Dunhua from 2003 to 2008. The average yield of the FX01 group was 2.47 kg/m2 in a production experiment, which is 0.41 kg/m2 higher than the local control. Interestingly, the highest yields for each year were all observed at the Fusong experimental site. In 2009, FX01 passed the examination and was registered as Fuxing 01 (Figure 3).

5.4. Fuxing 02

Fuxing 02 was also selected from the landrace Damaya, but it differs from Fuxing 01. Fuxing 02 has a high yield and ginsenoside content, a long growth period, and long main root length. Originally, 2900 excellent ginseng plants were selected in 1983, each with a main root length of more than 8 cm. Each plant was self-fertilized in 1984, and only 521 plants were reserved after removing plants that were diseased, had bad growth status, or produced few seeds. The seeds from each plant were harvested and bred into an inbred line. The inbred line was discarded whenever more than 50% of plants in any generation had a main root length of less than 8 cm. After selection for three generations, twelve inbred lines remained, and comparisons between them were carried out from 1995 to 1999. Inbred line 16 showed the best performance on yield, ginsenoside content, main root length, and survival rate. In regional and production experiments, the average yield increment of line 16 was 10.26% and 10.65%, respectively, compared with the local control. In 2014, line 16 was registered as Fuxing 02 (Figure 3).

5.5. Kangmei 01

Kangmei 01 is the first farmland ginseng cultivar in China. As deforestation has limited the availability of traditional shaded fields, planting ginseng in open farmland has increased in China. However, ginseng cultivars bred to grow in forests have shown poor adaptability to the very different soil and climatic conditions found in farmland. Therefore, ginseng cultivars adapted to farmland are needed. To breed a farmland ginseng cultivar, 7730 ginseng seedlings whose root diameter and root weight were more than 2.0 cm and 25 g, respectively, at three years old and more than 2.2 cm and 33 g, respectively, at four years old were selected from the Damaya population. These selected lines were transplanted to farmland, and 26 kg seeds were harvested in 1991 (Figure 3). Then, those ginseng seeds were sown on farmland, and variants were removed from the group. The group was propagated and purified for another two generations and then named DD1. The breeders found that plants in the DD1 group often developed more than two stems (multi-stem plants). Regional and production experiments of DD1 were performed from 2006 to 2010. For different experiment sites and years, the yield of DD1 increased by 13.16% to 19.20% compared to local controls. Additionally, the multi-stem rate of DD1 plants was higher than 50% when the investigation was carried out on four-year-old ginseng plants. Eventually, DD1 was registered in 2012 as Kangmei 01 with the characteristics of high yield, robust roots, multi-stem, and good adaptability to farmland.

5.6. Xinkaihe 01

Biantiao ginseng has a beautiful root, with a long main root and branch root, consistent root diameter along the main root, and humanoid shape with a round shoulder and neck. To produce Biantiao ginseng, special cultivation methods and germplasm resources are needed. Because of its complicated cultivation procedure and low success rate, the price of Biantiao ginseng is much higher than that of common ginseng. Xinkaihe 01 was bred to produce high-quality Biantiao ginseng with a higher success rate. An Ermaya population produced through artificial selection and specific environmental factors in the Xinkai river basin was selected as the original material for breeding. A total of 3788 individuals that met the criteria for Biantiao ginseng were selected from that Ermaya population to construct a Biantiao group. The Biantiao group was propagated for four generations in an isolated field, and unqualified individuals were removed. This group showed a significantly higher yield, main root length, and Biantiao ratio compared with the local control in regional and production experiments. In 2013, this Biantiao group was designated as the ginseng cultivar Xinkaihe 01 (Figure 3).

5.7. Xinkaihe 02

The ginseng cultivar Xinkaihe 02 was bred from the same Ermaya population as Xinkaihe 01, but it has a shorter rhizome than Xinkaihe 01. The breeding procedure for Xinkaihe 02 was similar to that for Xinkaihe 01, and the new cultivar was registered in 2016. Xinkaihe 02 has a long main root and short rhizome and is suitable for the production of model red ginseng (Figure 3).

5.8. Zhongnong Huangfengshen

Continuous cropping obstacles are one of the most important problems in ginseng cultivation. After ginseng has grown in it, a field requires about 30 years to recover enough for ginseng to be replanted. Although many techniques have been applied to improve the soil after ginseng harvest, continuous cropping of ginseng on a field is still hindered by fallen fibrous roots, rotten roots, and severe yield loss [102]. Therefore, breeding a ginseng cultivar resistant to those continuous cropping obstacles has been proposed. To breed a ginseng cultivar suitable for continuous cropping, 3000 high-resistance ginseng plants were screened from the Baoquanshan population. This high-resistance group was propagated in a single field for three generations. In each generation, nearly 50% of the plants were dead, and the remaining plants were named group ZH01. In regional and production experiments, the yield of ZH01 was at least 98% higher than that of the local control when grown continuously on a ginseng field and at least 9.9% higher when grown in a forested field. Furthermore, ZH01 showed a more flourishing fibrous root than the control, especially when grown continuously in a single field. ZH01 was registered as Zhongnong Huangfengshen in 2016 (Figure 3).

5.9. Zhongda Linxiashen

Zhongda Linxiashen is the only forest ginseng cultivar in China. Initially, 4700 forest ginseng plants with a beautiful humanoid root shape, long rhizome, and long fibrous roots were collected from the Changbai mountains. The seeds of those plants were harvested together and sown in an isolated field. The traits of the underground parts were investigated when the F1 plants were ten years old. The plants that did not achieve the breeding targets were discarded, and the seeds of the remaining plants were harvested. This procedure was repeated for four generations, and the elimination rates were 51.2%, 39.8%, 31.6%, and 25.5% for F1–F4, respectively (Figure 3). In regional and production experiments, the percentage of high-quality ginseng (higher than grade 2 according to the national standard, Identification and Grade Quality Standards of Wild Ginseng GB/T 18765-2015/2008) from this group was at least 35.6%, whereas the maximum percentage from the local control was 24.2%. This ginseng cultivar was designated as Zhongda Linxiashen and registered in 2016.

5.10. Summary of Panax ginseng Cultivars in China

Most ginseng cultivars (Jilin Huangguo Renshen, Jishen 01, Fuxing 01, Fuxing 02, Kangmei 01, Xinkaihe 01, and Xinkaihe 02) were bred in Fusong and Ji’an, which account for half of the area of ginseng cultivation in China. From 1960 until the 1990s, the major target traits in ginseng breeding were yield, root shape, and ginsenoside content. When deforestation created a shortage of fields suitable for ginseng cultivation in the late 1990s, breeders changed their focus to cultivars amenable to farmland and continuous cropping. As it takes about fifty years to breed a forest ginseng cultivar, only one forest ginseng cultivar is currently registered. Among the Chinese ginseng cultivars, Jishen 01, Fuxing 01, and Fuxing 02 are representative high yield cultivars. Xinkaihe 01 and Xinkaihe 02, with long main roots, were bred specifically for Biantiao ginseng production. Jilin Huangguo Renshen is the only cultivar bearing yellow fruit; the others all have red fruit. Kangmei 01 is suitable for farmland growing, and Zhongnong Huangfengshen is highly resistant to the obstacles common with continuous cropping. Zhongda Linxiashen has a beautiful root shape and is used to produce high-quality wild ginseng.

6. Conclusion and Future Prospects

The main goal of this review has been to profile all Korean and Chinese P. ginseng cultivars in terms of their good characteristics. The major purpose of P. ginseng cultivar selection has been to elaborate those with the quality of red ginseng, good physical properties, resistance to disease, resistance to root rot, high yield, and high saponin content. Also, selected cultivars should be superior to a previous cultivar or its landraces. Accordingly, different cultivars have been developed to overcome problems commonly faced during ginseng root growth, control biotic and abiotic stress, and increase useful bioactive components. Therefore, this review will enable readers to select ginseng cultivars suitable for a healthy life. In the future, the characteristics of existing cultivars can continue to be improved, and new cultivars of other Panax species can be developed by inter- or intraspecific hybridization.

Funding

This study was supported by a grant from the Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry & Fisheries (KIPET NO: 317007-3), Republic of Korea.

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Wang H., Xu F., Wang X., Kwon W.S., Yang D.C. Molecular discrimination of Panax ginseng cultivar K-1 using pathogenesis-related protein 5 gene. J. Ginseng Res. 2019;43:482–487. doi: 10.1016/j.jgr.2018.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kim Y.J., Zhang D., Yang D.C. Biosynthesis and biotechnological production of ginsenosides. Biotechnol. Adv. 2015;33:717–735. doi: 10.1016/j.biotechadv.2015.03.001. [DOI] [PubMed] [Google Scholar]
  • 3.Choi K.T. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol. Sin. 2008;29:1109–1118. doi: 10.1111/j.1745-7254.2008.00869.x. [DOI] [PubMed] [Google Scholar]
  • 4.Mohanan P., Subramaniyam S., Mathiyalagan R., Yang D.C. Molecular signaling of ginsenosides Rb1, Rg1, and Rg3 and their mode of actions. J. Ginseng Res. 2018;42:123–132. doi: 10.1016/j.jgr.2017.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Leung K.W., Wong A.S. Pharmacology of ginsenosides: A literature review. Chin. Med. 2010;5:20. doi: 10.1186/1749-8546-5-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cho C.-W., Kim Y.-C., Rhee Y.K., Lee Y.-C., Kim K.-T., Hong H.-D. Chemical composition characteristics of Korean straight ginseng products. J. Ethn. Foods. 2014;1:24–28. doi: 10.1016/j.jef.2014.11.007. [DOI] [Google Scholar]
  • 7.Chen X., Zhou H., Liu Y.B., Wang J.F., Li H., Ung C.Y., Han L.Y., Cao Z.W., Chen Y.Z. Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation. Br. J. Pharmacol. 2006;149:1092–1103. doi: 10.1038/sj.bjp.0706945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Shi Z.Y., Zeng J.Z., Tsai Wong A.S. Chemical structures and pharmacological profiles of ginseng saponins. Molecules. 2019;24:2443. doi: 10.3390/molecules24132443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yun T.-K. The spiritual nature of ginseng in the fareast. Korean Acad. Med. Sci. 2001;16 [Google Scholar]
  • 10.Choi J.G., Eom S.M., Kim J., Kim S.H., Huh E., Kim H., Lee Y., Lee H., Oh M.S. A Comprehensive Review of Recent Studies on Herb-Drug Interaction: A Focus on Pharmacodynamic Interaction. J. Altern. Complement. Med. 2016;22:262–279. doi: 10.1089/acm.2015.0235. [DOI] [PubMed] [Google Scholar]
  • 11.Wayne M. Ginseng: King of All Herbs -Holistic Health. [(accessed on 1 February 2020)]; Available online: https://blog.timesunion.com/holistichealth/ginseng-king-of-all-herbs/18032/
  • 12.Lee J.S., Choi H.S., Kang S.W., Chung J.H., Park H.K., Ban J.Y., Kwon O.Y., Hong H.P., Ko Y.G. Therapeutic effect of Korean red ginseng on inflammatory cytokines in rats with focal cerebral ischemia/reperfusion injury. Am. J. Chin. Med. 2011;39:83–94. doi: 10.1142/S0192415X1100866X. [DOI] [PubMed] [Google Scholar]
  • 13.Ramesh T., Kim S.W., Hwang S.Y., Sohn S.H., Yoo S.K., Kim S.K. Panax ginseng reduces oxidative stress and restores antioxidant capacity in aged rats. Nutr. Res. 2012;32:718–726. doi: 10.1016/j.nutres.2012.08.005. [DOI] [PubMed] [Google Scholar]
  • 14.Jang M.H., Piao X.L., Kim J.M., Kwon S.W., Park J.H. Inhibition of cholinesterase and amyloid-&bgr; aggregation by resveratrol oligomers from Vitis amurensis. Phyther. Res. 2008;22:544–549. doi: 10.1002/ptr.2406. [DOI] [PubMed] [Google Scholar]
  • 15.Jung J.H., Kang I.G., Kim D.Y., Hwang Y.J., Kim S.T. The effect of Korean red ginseng on allergic inflammation in a murine model of allergic rhinitis. J. Ginseng Res. 2013;37:167–175. doi: 10.5142/jgr.2013.37.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rhee M.-Y., Kim Y.-S., Bae J.-H., Nah D.-Y., Kim Y.-K., Lee M.-M., Kim H.-Y. Effect of Korean Red Ginseng on Arterial Stiffness in Subjects with Hypertension. J. Alternative Complementary Med. 2011;17:45–49. doi: 10.1089/acm.2010.0065. [DOI] [PubMed] [Google Scholar]
  • 17.Geng J., Dong J., Ni H., Lee M.S., Wu T., Jiang K., Wang G., Zhou A.L., Malouf R. Ginseng for cognition. Cochrane Database Syst. Rev. 2010;12 doi: 10.1002/14651858.CD007769.pub2. [DOI] [PubMed] [Google Scholar]
  • 18.Jang D.J., Lee M.S., Shin B.C., Lee Y.C., Ernst E. Red ginseng for treating erectile dysfunction: A systematic review. Br. J. Clin. Pharmacol. 2008;66:444–450. doi: 10.1111/j.1365-2125.2008.03236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wah Leung K., Wong A.S. Spermatogenesis Ginseng and male reproductive function. Spermatogenesis. 2013;3:e26391. doi: 10.4161/spmg.26391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yuan H.D., Kim J.T., Kim S.H., Chung S.H. Ginseng and diabetes: The evidences from in vitro, animal and human studies. J. Ginseng Res. 2012;36:27–39. doi: 10.5142/jgr.2012.36.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kang J.H., Song K.H., Woo J.K., Park M.H., Rhee M.H., Choi C., Oh S.H. Ginsenoside Rp1 from Panax ginseng Exhibits Anti-cancer Activity by Down-regulation of the IGF-1R/Akt Pathway in Breast Cancer Cells. Plant Foods Hum. Nutr. 2011;66:298–305. doi: 10.1007/s11130-011-0242-4. [DOI] [PubMed] [Google Scholar]
  • 22.Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 1999;58:1685–1693. doi: 10.1016/S0006-2952(99)00212-9. [DOI] [PubMed] [Google Scholar]
  • 23.Waminal N.E., Park H.M., Ryu K.B., Kim J.H., Yang T.J., Kim H.H. Karyotype analysis of Panax ginseng C.A.Meyer, 1843 (Araliaceae) based on rDNA loci and DAPI band distribution. Comp. Cytogenet. 2012;6:425–441. doi: 10.3897/CompCytogen.v6i4.3740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wong A.S.T., Che C.M., Leung K.W. Recent advances in ginseng as cancer therapeutics: A functional and mechanistic overview. Nat. Prod. Rep. 2015;32:256–272. doi: 10.1039/C4NP00080C. [DOI] [PubMed] [Google Scholar]
  • 25.Wang Y., Choi H.K., Brinckmann J.A., Jiang X., Huang L. Chemical analysis of Panax quinquefolius (North American ginseng): A review. J. Chromatogr. A. 2015;1426:1–15. doi: 10.1016/j.chroma.2015.11.012. [DOI] [PubMed] [Google Scholar]
  • 26.Ng T.B. Pharmacological activity of sanchi ginseng ( Panax notoginseng ) J. Pharm. Pharmacol. 2006;58:1007–1019. doi: 10.1211/jpp.58.8.0001. [DOI] [PubMed] [Google Scholar]
  • 27.Zou K., Zhu S., Meselhy M.R., Tohda C., Cai S., Komatsu K. Dammarane-type saponins from Panax japonicus and their neurite outgrowth activity in SK-N-SH cells. J. Nat. Prod. 2002;65:1288–1292. doi: 10.1021/np0201117. [DOI] [PubMed] [Google Scholar]
  • 28.Konoshima T., Takasaki M., Tokuda H., Nishino H., Duc N.M., Kasai R., Yamasaki K. Anti-tumor-promoting Activity of Majonoside-R2 from Vietnamese Ginseng, Panax vietnamensis HA et GRUSHV. (I) Biol. Pharm. Bull. 1998;21:834–838. doi: 10.1248/bpb.21.834. [DOI] [PubMed] [Google Scholar]
  • 29.Hesam Shahrajabian M. A review of Ginseng species in different regions as a multipurpose herb in traditional Chinese medicine, modern herbology and pharmacological science. J. Med. Plants Res. 2019;13:213. [Google Scholar]
  • 30.Hu X., Neill S., Cai W., Tang Z. Hydrogen peroxide and jasmonic acid mediate oligogalacturonic acid-induced saponin accumulation in suspension-cultured cells of Panax ginseng. Physiol. Plant. 2003;118:414–421. doi: 10.1034/j.1399-3054.2003.00124.x. [DOI] [Google Scholar]
  • 31.Yan X., Fan Y., Wei W., Wang P., Liu Q., Wei Y., Zhang L., Zhao G., Yue J., Zhou Z. Production of bioactive ginsenoside compound K in metabolically engineered yeast. Cell Res. 2014;24:770–773. doi: 10.1038/cr.2014.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Han J.Y., Kim M.J., Ban Y.W., Hwang H.S., Choi Y.E. The involvement of β-amyrin 28-oxidase (cyp716a52v2) in oleanane-type ginsenoside biosynthesis in panax ginseng. Plant Cell Physiol. 2013;54:2034–2046. doi: 10.1093/pcp/pct141. [DOI] [PubMed] [Google Scholar]
  • 33.Jeong G.T., Park D.H. Enhanced secondary metabolite biosynthesis by elicitation in transformed plant root system: Effect of abiotic elicitors. Appl. Biochem. Biotechnol. 2006;130:436–446. doi: 10.1385/ABAB:130:1:436. [DOI] [PubMed] [Google Scholar]
  • 34.Kaliraj L., Ahn J.C., Rupa E.J., Abid S., Lu J., Yang D.C. Synthesis of panos extract mediated ZnO nano-flowers as photocatalyst for industrial dye degradation by UV illumination. J. Photochem. Photobiol. B Biol. 2019;199:111588. doi: 10.1016/j.jphotobiol.2019.111588. [DOI] [PubMed] [Google Scholar]
  • 35.Park S., Park J., Kim H., Lee C., Lee H., Kang K.S., Kim C. Systems-level mechanisms of action of Panax ginseng: A network pharmacological approach. J. Ginseng Res. 2018;42:98–106. doi: 10.1016/j.jgr.2017.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ling W.H., Jones P.J.H. Dietary phytosterols: A review of metabolism, benefits and side effects. Life Sci. 1995;57:195–206. doi: 10.1016/0024-3205(95)00263-6. [DOI] [PubMed] [Google Scholar]
  • 37.Murakami A. Studies on the Sesquiterpenoids of Panax ginseng C. A. Meyer. IV. Chem. Pharm. Bull. 1970:2091. doi: 10.1248/cpb.38.1405. [DOI] [PubMed] [Google Scholar]
  • 38.Richter R., Basar S., Koch A., König W.A. Three sesquiterpene hydrocarbons from the roots of Panax ginseng C.A. Meyer (Araliaceae) Phytochemistry. 2005;66:2708–2713. doi: 10.1016/j.phytochem.2005.09.012. [DOI] [PubMed] [Google Scholar]
  • 39.Kumar S., Pandey A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013;2013:16. doi: 10.1155/2013/162750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Murakami A. Cytotoxic Activity of Polyacetylene Compounds in Panax ginseng C. A. Meyer. Chem. Pharm. Bull. 1970;2091:3480–3482. doi: 10.1248/cpb.38.3480. [DOI] [PubMed] [Google Scholar]
  • 41.Han B.H., Park M.H., Han Y.N., Woo L.K. Alkaloidal components of Panax ginseng. Arch. Pharm. Res. 1986;9:21–23. doi: 10.1007/BF02857702. [DOI] [Google Scholar]
  • 42.Lee L.S., Cho C.W., Hong H.D., Lee Y.C., Choi U.K., Kim Y.C. Hypolipidemic and antioxidant properties of phenolic compound-rich extracts from white ginseng (Panax ginseng) in cholesterol-fed rabbits. Molecules. 2013;18:12548–12560. doi: 10.3390/molecules181012548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Cho I.H., Lee H.J., Kim Y.S. Differences in the volatile compositions of ginseng species (Panax sp.) J. Agric. Food Chem. 2012;60:7616–7622. doi: 10.1021/jf301835v. [DOI] [PubMed] [Google Scholar]
  • 44.Abid S., Mohanan P., Kaliraj L., Park J.K., Ahn J.C., Yang D.C. Development of species-specific chloroplast markers for the authentication of Gynostemma pentaphyllum and their distribution in the Korean peninsula. Fitoterapia. 2019;138:104295. doi: 10.1016/j.fitote.2019.104295. [DOI] [PubMed] [Google Scholar]
  • 45.Pandey A.K., Ajmal Ali M., Mao A.A. Genus Panax L. (Araliaceae) in India. 2nd ed. Pleione; Shillong, India: 2007. pp. 46–54. [Google Scholar]
  • 46.Yun T.K. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 2001;16(Suppl. S3) doi: 10.3346/jkms.2001.16.S.S3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kim D.H. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J. Ginseng Res. 2012;36:1–15. doi: 10.5142/jgr.2012.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sukweenadhi J., Choi J.Y., Kim Y.J., Kaliraj L., Abid S., Ahn J.C., Yang D.C. Callus induction and in vitro mass culture of adventitious roots from leaf segment explants of Dendropanax morbifera Lev. IOP Conf. Ser. Earth Environ. Sci. 2019;293 doi: 10.1088/1755-1315/293/1/012024. [DOI] [Google Scholar]
  • 49.Mahler W.F., Shinners L.H. SIDA, Contributions to Botany. Biodiversity Heritage Library; Dallas, TX, USA: 1985. [(accessed on 20 March 2020)]. Available online: https://www.biodiversitylibrary.org/item/38226. [Google Scholar]
  • 50.Robinson B.L., Fernald M.L., Club N.E.B. Rhodora. [(accessed on 4 June 2020)];New Engl. Botanical. Club. 1984 Available online: https://www.biodiversitylibrary.org/bibliography/721. [Google Scholar]
  • 51.MORITA T., TANAKA O., KOHDA H. Saponin composition of rhizomes of Panax japonicus collected in South Kyushu, Japan, and its significance in oriental traditional medicine. Chem. Pharm. Bull. 1985;33:3852–3858. doi: 10.1248/cpb.33.3852. [DOI] [PubMed] [Google Scholar]
  • 52.Yamahara J., Kubomura Y., Miki K., Fujimura H. Anti-ulcer action of Panax japonicus rhizome. J. Ethnopharmacol. 1987;19:95–101. doi: 10.1016/0378-8741(87)90141-3. [DOI] [PubMed] [Google Scholar]
  • 53.Hanif M.A., Duah Boakye Y., Agyare C. Natural Products as Inductors for Celluar Differentiation of Human Keratinocytes View Project Antibiotic Resistance Transfer View Project. [(accessed on 20 March 2020)]; Available online: https://www.researchgate.net/publication/336364672.
  • 54.Tanaka O., Yahara S. Dammarane saponins of leaves of Panax pseudo-ginseng subsp. himalaicus. Phytochemistry. 1978;17:1353–1358. doi: 10.1016/S0031-9422(00)94588-6. [DOI] [Google Scholar]
  • 55.Dua P.R., Shanker G., Srimal R.C., Saxena K.C., Saxena R.P., Puri A., Dhawan B.N., Shukla Y.N., Thakur R.S., Husain A. Adaptogenic activity of Indian Panax pseudoginseng. Indian J. Exp. Biol. 1989;27:631–634. [PubMed] [Google Scholar]
  • 56.Lee C., Wen J. Phylogeny of Panax using chloroplast trnC-trnD intergenic region and the utility of trnC-trnD in interspecific studies of plants. Mol. Phylogenet. Evol. 2004;31:894–903. doi: 10.1016/j.ympev.2003.10.009. [DOI] [PubMed] [Google Scholar]
  • 57.Ali M.A., Lee J., Choudhary R.K., Pandey A. Assessing nrDNA ITS2 sequence based molecular signature of ginseng for potential use in quality control of drug Molecular phylogenetics of Trigonella and Melilotus View project Systematics of Alysicarpus, Crotalaria and Indigofera (Fabaceae) View project. Afr. J. Pharm. Pharmacol. 2012;6:2775–2781. [Google Scholar]
  • 58.Nguyen S.G., Long P.K. A new ginseng species Panax sp. (Araliaceae) in Vietnam. [(accessed on 20 March 2020)];J. Pharm. 2011 426:59–63. Available online: https://www.researchgate.net/publication/261357183. [Google Scholar]
  • 59.Wen J., Zimmer E.A. Phylogeny and Biogeography of Panax L. (the Ginseng Genus, Araliaceae): Inferences from ITS Sequences of Nuclear Ribosomal DNA. Mol. Phylogenetics Evol. 1996;6:167–177. doi: 10.1006/mpev.1996.0069. [DOI] [PubMed] [Google Scholar]
  • 60.Sharma S.K., Pandit M.K. A New Species of Panax L. (Araliaceae) from Sikkim Himalaya, India. Syst. Bot. 2009;34:434–438. doi: 10.1600/036364409788606235. [DOI] [Google Scholar]
  • 61.Jenner H., Townsend B., Osbourn A. Unravelling triterpene glycoside synthesis in plants: Phytochemistry and functional genomics join forces. Planta. 2005;220:503–506. doi: 10.1007/s00425-004-1434-z. [DOI] [PubMed] [Google Scholar]
  • 62.Yang W.Z., Hu Y., Wu W.Y., Ye M., Guo D.A. Saponins in the genus Panax L. (Araliaceae): A systematic review of their chemical diversity. Phytochemistry. 2014;106:7–24. doi: 10.1016/j.phytochem.2014.07.012. [DOI] [PubMed] [Google Scholar]
  • 63.Kitts D.D., Hu C. Efficacy and safety of ginseng. Public Health Nutr. 2000;3:473–485. doi: 10.1017/S1368980000000550. [DOI] [PubMed] [Google Scholar]
  • 64.Patel S., Rauf A. Adaptogenic herb ginseng (Panax) as medical food: Status quo and future prospects. Biomed. Pharmacother. 2017;85:120–127. doi: 10.1016/j.biopha.2016.11.112. [DOI] [PubMed] [Google Scholar]
  • 65.Liu S., Zhong J.J. Phosphate effect on production of ginseng saponin and polysaccharide by cell suspension cultures of Panax ginseng and Panax quinquefolium. Process Biochem. 1998;33:69–74. doi: 10.1016/S0032-9592(97)00064-2. [DOI] [Google Scholar]
  • 66.Kochkin D.V., Kachala V.V., Shashkov A.S., Chizhov A.O., Chirva V.Y., Nosov A.M. Malonyl-ginsenoside content of a cell-suspension culture of Panax japonicus var. repens. Phytochemistry. 2013;93:18–26. doi: 10.1016/j.phytochem.2013.03.021. [DOI] [PubMed] [Google Scholar]
  • 67.Kang S., Min H. Ginseng, the “immunity boost”: The effects of panax ginseng on immune system. J. Ginseng Res. 2012;36:354–368. doi: 10.5142/jgr.2012.36.4.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Kim H.A., Kim S., Chang S.H., Hwang H.J., Choi Y. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int. Immunopharmacol. 2007;7:1286–1291. doi: 10.1016/j.intimp.2007.05.006. [DOI] [PubMed] [Google Scholar]
  • 69.Kim K.R., Chung T.Y., Shin H., Son S.H., Park K.K., Choi J.H., Chung W.Y. Red ginseng saponin extract attenuates murine collagen-induced arthritis by reducing pro-inflammatory responses and matrix metalloproteinase-3 expression. Biol. Pharm. Bull. 2010;33:604–610. doi: 10.1248/bpb.33.604. [DOI] [PubMed] [Google Scholar]
  • 70.Cabral de Oliveira A.C., Perez A.C., Merino G., Prieto J.G., Alvarez A.I. Protective effects of Panax ginseng on muscle injury and inflammation after eccentric exercise. Comp. Biochem. Physiol.-C Toxicol. Pharmacol. 2001;130:369–377. doi: 10.1016/S1532-0456(01)00262-9. [DOI] [PubMed] [Google Scholar]
  • 71.Oh S.J., Kim K., Lim C.J. Suppressive properties of ginsenoside Rb2, a protopanaxadiol-type ginseng saponin, on reactive oxygen species and matrix metalloproteinase-2 in UV-B-irradiated human dermal keratinocytes. Biosci. Biotechnol. Biochem. 2015;79:1075–1081. doi: 10.1080/09168451.2015.1020752. [DOI] [PubMed] [Google Scholar]
  • 72.Yu T., Yang Y., Kwak Y.S., Song G.G., Kim M.Y., Rhee M.H., Cho J.Y. Ginsenoside Rc from Panax ginseng exerts anti-inflammatory activity by targeting TANK-binding kinase 1/interferon regulatory factor-3 and p38/ATF-2. J. Ginseng Res. 2017;41:127–133. doi: 10.1016/j.jgr.2016.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Yu T., Yang Y., Yin D.Q., Hong S., Son Y.J., Kim J.H., Cho J.Y. TBK1 inhibitors: A review of patent literature (2011 - 2014) Expert Opin. Ther. Pat. 2015;25:1385–1396. doi: 10.1517/13543776.2015.1081168. [DOI] [PubMed] [Google Scholar]
  • 74.Kim J.H. Pharmacological and medical applications of Panax ginseng and ginsenosides: A review for use in cardiovascular diseases. J. Ginseng Res. 2018;42:264–269. doi: 10.1016/j.jgr.2017.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Lü J.-M., Yao Q., Chen C. Ginseng Compounds: An Update on Their Molecular Mechanisms and Medical Applications. Curr. Vasc. Pharmacol. 2009;7:293–302. doi: 10.2174/157016109788340767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Kim J.H. Cardiovascular diseases and panax ginseng: A review on molecular mechanisms and medical applications. J. Ginseng Res. 2012;36:16–26. doi: 10.5142/jgr.2012.36.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Chen C.F., Chiou W.F., Zhang J.T. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol. Sin. 2008;29:1103–1108. doi: 10.1111/j.1745-7254.2008.00868.x. [DOI] [PubMed] [Google Scholar]
  • 78.Qi X., Ignatova S., Luo G., Liang Q., Jun F.W., Wang Y., Sutherland I. Preparative isolation and purification of ginsenosides Rf, Re, Rd and Rb1 from the roots of Panax ginseng with a salt/containing solvent system and flow step-gradient by high performance counter-current chromatography coupled with an evaporative light sca. J. Chromatogr. A. 2010;1217:1995–2001. doi: 10.1016/j.chroma.2010.01.057. [DOI] [PubMed] [Google Scholar]
  • 79.Mogil J.S., Shin Y.H., McCleskey E.W., Kim S.C., Nah S.Y. Ginsenoside RF, a trace component of ginseng root, produces antinociception in mice. Brain Res. 1998;792:218–228. doi: 10.1016/S0006-8993(98)00133-4. [DOI] [PubMed] [Google Scholar]
  • 80.Li C.T., Wang H.B., Xu B.J. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and anticoagulant activities of ginsenosides Rg1 and Rg2. Pharm. Biol. 2013;51:1077–1080. doi: 10.3109/13880209.2013.775164. [DOI] [PubMed] [Google Scholar]
  • 81.Li N., Liu B., Dluzen D.E., Jin Y. Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J. Ethnopharmacol. 2007;111:458–463. doi: 10.1016/j.jep.2006.12.015. [DOI] [PubMed] [Google Scholar]
  • 82.Zhang H., Lu Z., Tan G.T., Qiu S., Farnsworth N.R., Pezzuto J.M., Fong H.H.S. Polyacetyleneginsenoside-Ro, a novel triterpene saponin from Panax ginseng. Tetrahedron Lett. 2002;43:973–977. doi: 10.1016/S0040-4039(01)02310-3. [DOI] [Google Scholar]
  • 83.Kim H.J., Kim P., Shin C.Y. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J. Ginseng Res. 2013;37:8–29. doi: 10.5142/jgr.2013.37.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Kwon W.-S., Chung C.-M., Kim Y.-T., Lee M.-G., Choi K.-T. Breeding Process and Characteristics of KG101, a Superior Line of Panax ginseng CA Meyer. J. Ginseng Res. 1998;22:11–17. [Google Scholar]
  • 85.Joh H.J., Kim N.-H., Jayakodi M., Jang W., Park J.Y., Kim Y.C., In J.-G., Yang T.-J. Authentication of Golden-Berry P. ginseng Cultivar ‘Gumpoong’ from a Landrace ‘Hwangsook’ Based on Pooling Method Using Chloroplast-Derived Markers. Plant Breed. Biotechnol. 2017;5:16–24. doi: 10.9787/PBB.2017.5.1.16. [DOI] [Google Scholar]
  • 86.Seo K.H., Mohanan P., Yang D.U., Kim Y.J., Kwon W.S., Yang D.C. Interspecies hybrids of Panax ginseng Meyer new line 0837 and Panax quinquefolius generated superior F1 hybrids with greater biomass and ginsenoside contents. Hortic. Environ. Biotechnol. 2019;60:573–583. doi: 10.1007/s13580-019-00154-4. [DOI] [Google Scholar]
  • 87.Kim Y.J., Silva J., Zhang D., Shi J., Joo S.C., Jang M.G., Kwon W.S., Yang D.C. Development of interspecies hybrids to increase ginseng biomass and ginsenoside yield. Plant Cell Rep. 2016;35:779–790. doi: 10.1007/s00299-015-1920-8. [DOI] [PubMed] [Google Scholar]
  • 88.Wang H., Sun H., Kwon W.S., Jin H., Yang D.C. Molecular identification of the Korean ginseng cultivar chunpoong using the mitochondrial nad7 intron 4 region. Mitochondrial DNA. 2009;20:41–45. doi: 10.1080/19401730902856738. [DOI] [PubMed] [Google Scholar]
  • 89.Kwon W.-S., Lee M.-G., Choi K.-T. Breeding Process and Characteristics of Yunpoong, a New Variety of Panax ginseng C.A. Meyer. J. Ginseng Res. 2000;24:1–7. [Google Scholar]
  • 90.Kwon W.S., Lee J.H., Park C.S. Breeding Process and Characteristics of Gopoong, a New Variety of Panax ginseng C.A. Meyer. J. Ginseng Res. 2003;27:86–91. [Google Scholar]
  • 91.Lee J.H., Lee J.S., Kwon W.S., Kang J.Y., Lee D.Y., In J.G., Kim Y.S., Seo J., Baeg I.H., Chang I.M., et al. Characteristics of korean ginseng varieties of Gumpoong, Sunun, Sunpoong, Sunone, Cheongsun, and Sunhyang. J. Ginseng Res. 2015;39:94–104. doi: 10.1016/j.jgr.2014.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Park M.J., Kim M.K., In J.G., Yang D.C. Molecular identification of Korean ginseng by amplification refractory mutation system-PCR. Food Res. Int. 2006;39:568–574. doi: 10.1016/j.foodres.2005.11.004. [DOI] [Google Scholar]
  • 93.Kim N.H., Choi H.I., Ahn I.O., Yang T.J. EST-SSR marker sets for practical authentication of all nine registered ginseng cultivars in Korea. J. Ginseng Res. 2012;36:298–307. doi: 10.5142/jgr.2012.36.3.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Lee Y.S., Park H.S., Lee D.K., Jayakodi M., Kim N.H., Lee S.C., Kundu A., Lee D.Y., Kim Y.C., Gyo In J., et al. Comparative analysis of the transcriptomes and primary metabolite profiles of adventitious roots of five panax ginseng cultivars. J. Ginseng Res. 2017;41:60–68. doi: 10.1016/j.jgr.2015.12.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Jo I.H., Bang K.H., Hong C.E., Kim J.U., Lee J.W., Kim D.H., Hyun D.Y., Ryu H., Kim Y.C. Analysis of the chloroplast genome and SNP detection in a salt tolerant breeding line in Korean ginseng. J. Plant Biotechnol. 2016;43:417–421. doi: 10.5010/JPB.2016.43.4.417. [DOI] [Google Scholar]
  • 96.Kim Y.C., Kim Y.B., Kim J.U., Lee J.W., Jo I.H., Bang K.H., Kim D.H., Kim K.H. Difference in Growth Characteristics of 5-Year-Old Ginseng Grown by Direct Seeding and Transplanting. Korean J. Med. Crop Sci. 2015;23:480–488. doi: 10.7783/KJMCS.2015.23.6.480. [DOI] [Google Scholar]
  • 97.Yang D.U., Kim M.K., Mohanan P., Mathiyalagan R., Seo K.H., Kwon W.S., Yang D.C. Development of a single-nucleotide-polymorphism marker for specific authentication of Korean ginseng (Panax ginseng Meyer) new cultivar “G-1”. J. Ginseng Res. 2017;41:31–35. doi: 10.1016/j.jgr.2015.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Kim Y.C., Kim J.U., Lee J.W., Hong C.E., Hwan Bang K., Kim D.H., Hyun D.Y., Choi J.K., Seong B.J., An Y.N., et al. ‘Kowon’, a New Korean Ginseng Cultivars with High Yield and Alternaria Blight Resistance. korean J. Hortic. Sci. 2017;35 [Google Scholar]
  • 99.Lee J.S., Lee J.H., Ahn I.O. Characteristics of resistant lines to high-temperature injury in ginseng (Panax ginseng C. A. Meyer) J. Ginseng Res. 2010;34:274–281. doi: 10.5142/jgr.2010.34.4.274. [DOI] [Google Scholar]
  • 100.Shoujing Z., Yunzhang L., Yahui Z., Fangyuan L., Zhaohui H., Lianju W., Jing G., Jiyong L. Comprehensive Evaluation on Characters of Jilin Yellow-Fruit ginseng. Spec. Wild Econ. Anim. Plant Res. 1998;4:1–6. [Google Scholar]
  • 101.Zhao S.J., Li F.Y., Zhao Y.H., Liu Y.Z., Sun C.W., Huang Z.H., Wu L.J., Jin Y.H. Studies on Selection Theory for High yield Variety of Panax ginseng and Breeding of Jishen 1. Sci. Agric. Sin. 1998;31:51–62. [Google Scholar]
  • 102.YING Y., DING W., ZHOU Y., LI Y. Influence of Panax ginseng Continuous Cropping on Metabolic Function of Soil Microbial Communities. Chin. Herb. Med. 2012;4:329–334. [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES